Adenosine and Ketogenic Treatments

Area of Science:

• Neuroscience
• Biochemistry
• Epilepsy Research

Background:

• Adenosine, a neuromodulator, inhibits seizures via adenosine A1 receptors.
• The ketogenic diet (KD) is effective for drug-refractory epilepsy.
• Adenosine was implicated in the KD's anticonvulsant mechanism in 2008.

Purpose of the Study:

• Review evidence linking adenosine, ketosis, and anticonvulsant/antiepileptogenic effects.
• Investigate the role of adenosine in the ketogenic state's impact on epilepsy.
• Explore potential therapeutic strategies involving adenosine.

Main Methods:

• Review of existing rodent models of epilepsy and seizures.
• Analysis of studies on ketogenic treatments (KD, ketone bodies, fatty acids).
• Examination of brain slice experiments mimicking ketogenic milieu.

Main Results:

• Antiseizure effects of ketogenic treatments are reversed by adenosine A1 receptor antagonists in rodent models.
• Ketogenic diet treatment increases extracellular and tissue adenosine levels in the brain.
• Ketogenic milieu in brain slices reduces neuronal excitability via adenosine A1 receptors.

Conclusions:

• Accumulating evidence supports an adenosinergic anticonvulsant action within the ketogenic state.
• Reduced brain glucose may be a key trigger for adenosine-mediated effects.
• Further research is needed on adenosine's role in antiepileptogenic and neuroprotective effects of KD.